Immunohistochemical expression of cyclooxygenase-2 in canine ovarian carcinomas

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 54, Issue 5, 2007, Pages 247-249

  Borzacchiello, G ^a   Russo, V ^a   Russo, M ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; CARCINOMA; DOG; DOG DISEASE; ENZYMOLOGY; FEMALE; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; OVARY TUMOR; PATHOLOGY;

ANIMALS; CARCINOMA; CYCLOOXYGENASE 2; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; OVARIAN NEOPLASMS;

ANIMALIA;

EID: 34249084977     PISSN: 0931184X     EISSN: 14390442     Source Type: Journal    
DOI: 10.1111/j.1439-0442.2007.00934.x     Document Type: Article

References (26)

1. Ali-Fehmi, R., M. Che, I. Khalifeh, J. M. Maione, R. Morris, W. D. Lawrence A. R. Munkarah, 2003 : The effect of cyclooxygenase-2 expression on tumor vascularity in advanced stage ovarian serous carcinoma. Cancer 98, 1423 1429.
2. Borzacchiello, G., V. Ambrosio, A. Perillo, P. Galati F. Roperto, 2003 : Cyclooxygenase-1 and -2 expression in urothelial carcinomas of cows. Vet. Pathol. 40, 455 459.
3. Borzacchiello, G., O. Paciello S. Papparella, 2004 : Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas. J. Comp. Pathol. 131, 233 236.
4. Dorè, M., I. Lanthier J. Sirois, 2003 : Cyclooxygenase-2 expression in canine mammary tumors. Vet. Pathol. 40, 207 212.
5. Herron, M. A., 1983 : Tumors of the canine genital system. J. Am. Anim. Hosp. Assoc. 19, 981 994.
6. Jones, T. C., R. D. Hunt N. W. King, 1997 : Veterinary Pathology, 6th edn, pp. 1159 1162. Williams and Wilkins, Baltimore, MD.
7. Kennedy, P.C., J.M. Cullen, J. F. Edwards, M. Goldschmidt, S. Larse, L. Munson S. Nielsen, 1998 : Histological classification of tumors of the genital system of domestic animals. World Health Organ. Int. Histol. Classif. Tumors Domest. Anim. 4, 24 31.
8. Khan, M. K. N., D. W. Knapp, D. Denicola K. R. Harris, 2000 : Expression of cyclooxygenase-2 in transitional cell carcinoma of the urinary bladder in dogs. Am. J. Vet. Res. 61, 478 481.
9. Khan, M. K. N., K. M. Stanfield, D. Trajkovic D. W. Knapp, 2001 : Expression of cyclooxygenase-2 in canine renal cell carcinoma. Vet. Pathol. 38, 116 119.
10. Kismet, K., M. T. Akay, O. Abbasoglu A. Ercan, 2004 : Celecoxib: a potent cyclooxygenase-2 inhibitor in cancer prevention. Cancer Detect. Prev. 28, 127 142.
11. Klimp, A., H. Hollema, C. Kempinga, A. G. J., Van der Zee, E. G. E. de Vries T. Daemen, 2001 : Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor associated macrophages. Cancer Res. 61, 7305 7309.
12. Knapp, D. W., R. C. Richardson, G. D. Bottoms, R. Teclaw T. C. Chan, 1992 : Phase I trial of piroxicam in 62 dogs bearing naturally occurring tumors. Cancer Chemother. Pharmacol. 29, 214 218.
13. Matsumoto, Y., O. Ishiko, M. Deguchi, E. Nakagawa S. Ogita, 2001 : Cyclooxygenase-2 expression in normal ovaries and epithelial ovarian neoplasms. Int. J. Mol. Med. 8, 31 36.
14. McEntee, M. E., J. M. Cates N. Nielsen, 2002 : Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs. Vet. Pathol. 39, 428 436.
15. Mohammed, S. I., B. A. Craig, A. J. Mutsaers, N. W. Glickman, P. W. Snyder, A. E. de Gortari, D. L. Schlittler, K. T. Coffman, P. L. Bonney D. W. Knapp, 2003 : Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Mol. Cancer Ther. 2, 183 188.
16. Moore, A. S., C. Kirk A. Cardona, 1991 : Intracavitary cisplatin chemotherapy: experience with six dogs. J. Vet. Intern. Med. 8, 227 231.
17. Patnaik, A. K. P. G. Greenlee, 1987 : Canine ovarian neoplasms: a clinicopathologic study of 71 cases, including histology of 12 granulosa cell tumors. Vet. Pathol. 24, 509 514.
18. Pestili de Almeida, E. M., C. Pichè, J. Sirois M. Dorè, 2001 : Expression of cyclo-oxygenase-2 in naturally occurring squamous cell carcinomas in dogs. J. Histochem. Cytochem. 49, 867 875.
19. Raspollini, M. R., G. Alunni, A. Villanucci, V. Boddi, G. Baroni, A. Taddei G. L. Taddei, 2004 : COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates. Oncol. Rep. 11, 309 313.
20. Rodriguez-Burford, C., M. N. Barnes, D. K. Oelschlager, R. B. Myers, L. I. Talley, E. E. Partridge W. E. Grizzle, 2002 : Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents. Clin. Cancer Res. 8, 202 209.
21. Smith, W. L., D. L. DeWitt R. M. Garavito, 2000 : Cyclooxygenases: structural, cellular and molecular biology. Annu. Rev. Biochem. 69, 145 182.
22. Subbaramaiah, K. A. J. Dannenberg, 2003 : Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol. Sci. 24, 96 102.
23. Taketo, M. M., 1998 : Cyclooxygenase-2 inhibitors in tumorigenesis. J. Natl. Cancer Inst. 90, 1609 1620.
24. Tremblay, C., M. Dorè, P. N. Bochsler, J. Sirois, 1999 : Induction of prostaglandin G/H synthase-2 in a canine model of spontaneous prostatic adenocarcinoma. J. Natl. Cancer Inst. 91, 1398 1403.
25. Wadleigh, D. J., S. T. Reddy, E. Kopp, S. Ghosh H. R. Herschman, 2000 : Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J. Biol. Chem. 275, 6259 6266.
26. Williams, C. S. R. N. Dubois, 1996 : Prostaglandin endoperoxidase synthase: why two isoforms Am. J. Physiol. 270, 393 400.